Llwytho...
Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections
No clinical breakpoints are available to delineate antifungal drug efficacy in non-Aspergillus invasive mold infections (NAIMIs). In this analysis of 39 NAIMI episodes, the MIC of the first-line antifungal drug was the most important predictor of therapeutic response. For amphotericin B, an MIC of ≤...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Clin Microbiol |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society for Microbiology
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879309/ https://ncbi.nlm.nih.gov/pubmed/27008871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00318-16 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|